Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda acquires Ariad Pharmaceuticals
Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash.
Manufacturing
-
17 Feb 2017
-
13 Feb 2017
Reckitt Benckiser to purchase Mead Johnson for $16.6bn
Reckitt Benckiser (RB) has agreed to acquire Mead Johnson Nutrition for $90 in cash for each share of common stock, valuing the total equity at $16.6bn.
-
03 Feb 2017
Arven selects GE Healthcare’s manufacturing platform to expand production capacity at Turkish facility
GE Healthcare’s FlexFactory manufacturing platform has been selected to expand production capacity at Arven Pharmaceuticals' facility in Kirklareli, Turkey.
-
10 Jan 2017
Takeda to buy Ariad Pharmaceuticals for $5.2bn
Japan's Takeda Pharmaceutical has agreed to acquire US cancer drug maker Ariad Pharmaceuticals in a transaction worth about $5.2bn.